Top Abstract Purchase Related
Home
>
Node
>
Subnode

Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma

Annals of the Academy of Medicine Singapore 44(10): 463-473

2015

ISSN/ISBN: 0304-4602
PMID: 26763064
Document Number: 681142
The SCAN Neuro-Oncology workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for systemic therapy for high-grade glioma in Singapore. The workgroup utilised a modified ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. Six international guidelines were evaluated- those developed by the National Comprehensive Cancer Network (2013), the European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma (2014), the European Society of Medical Oncology (2014), the Canadian GBM Recommendations Committee (2007) and the Australian Cancer Network (2009). Recommendations on the systemic therapy of high-grade glioma were produced. These adapted guidelines form the SCAN Guidelines 2015 for systemic therapy of high-grade glioma.

Document emailed within 1 workday
Secure & encrypted payments

2015: Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma (mRCC) Annals of the Academy of Medicine Singapore 44(10): 406-414
Tan, M.Han. 2015: The Singapore Cancer Network (SCAN) Guidelines: A New Beginning Annals of the Academy of Medicine Singapore 44(10): 358-359
2015: Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes Annals of the Academy of Medicine Singapore 44(10): 492-510
Direksunthorn, T.; Chawalparit, O.; Sangruchi, T.; Witthiwej, T.; Tritrakarn, S.-O.; Piyapittayanan, S.; Charnchaowanish, P.; Pornpunyawut, P.; Sathornsumetee, S. 2013: Diagnostic performance of perfusion MRi in differentiating low-grade and high-grade gliomas: advanced MRi in glioma, a Siriraj project Journal of the Medical Association of Thailand 96(9): 1183-1190
Kiatiyosnusorn, R.; Suprasert, P.; Srisomboon, J.; Siriaree, S.; Khunamornpong, S.; Kietpeerakool, C. 2010: High-grade histologic lesions in women with low-grade squamous intraepithelial lesion cytology from a region of Thailand with a high incidence of cervical cancer International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 110(2): 133-136
Aoki, H.; Natsumeda, M.; Abe, E.; Uzuka, T.; Kobayashi, T.; Aoyama, H.; Fujii, Y. 2012: Short course radiotherapy in elderly patients with high-grade glioma No Shinkei Geka. Neurological Surgery 40(7): 593-598
Chansriwong, P.; Sirisinha, T. 2010: Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital Journal of the Medical Association of Thailand 93(Suppl 2): S68-S73
Würschmidt, F.; Bünemann, H.; Heilmann, H.P. 1995: Prognostic factors in high-grade malignant glioma. a multivariate analysis of 76 cases with postoperative radiotherapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(6): 315-321
Ishikawa, E.; Yamamoto, T. 2016: Intraoperative BCNU Wafer Implantation for High-Grade Glioma--A Questionnaire Targeting Japanese Neurosurgeons Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 603-607
Swain, S.M.; Lippman, M.E. 1989: Systemic therapy of locally advanced breast cancer: review and guidelines Oncology 3(1): 21-8; Discussion 28-30 34
Ashley, D.M.; Kong, F.M.; Bigner, D.D.; Hale, L.P. 1998: Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model Cancer Research 58(2): 302-309
Tang, P.; Wang, X.; Schiffhauer, L.; Wang, J.; Bourne, P.; Yang, Q.; Quinn, A.; Hajdu, S. 2006: Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ Annals of Clinical and Laboratory Science 36(2): 137-143
Carlson, R.W.; Goldstein, L.J.; Gradishar, W.J.; Lichter, A.S.; McCormick, B.; Moe, R.E.; Theriault, R.L. 1996: NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network Oncology 10(11 Suppl): 47-75
1999: Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network Oncology 13(5a): 41-66
Obeidat, B.; Matalka, I.; Mohtaseb, A.; Jaradat, S.; Hayajneh, W.; Khasawneh, R.; Haddad, H.; Obeidat, F. 2013: Prevalence and distribution of high-risk human papillomavirus genotypes in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Jordanian women European Journal of Gynaecological Oncology 34(3): 257-260
Cook, J.A.; Glass, J.; Lebovics, R.; Bobo, H.; Pass, H.; DeLaney, T.F.; Oldfield, E.H.; Mitchell, J.B.; Glatstein, E.; Goffman, T.E. 1992: Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine Cancer Research 52(3): 719-725
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330
Roumen, R.M. 2000: Prognostic benefits evaluated: new guidelines for systemic adjuvant therapy for axillary node-negative breast cancer vs. implementation of sentinel node biopsy procedure Nederlands Tijdschrift Voor Geneeskunde 144(21): 980-984
1998: NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network Oncology 12(11a): 53-80
1999: NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network Oncology 13(5a): 113-147